Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-017562

Chief Strategy Officer sold 1,895 shares at $6.84 ($12,962)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Nayak Sanjay · Chief Strategy Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-24 Sale : show line 1 in the form 10b5-1 −1,895 $6.84 $12,962 283,485 D
Open-market sales · 1,895 sh · avg $6.84 · $12,962
Loading xslF345X05/tm257640-1_4seq1.xml…